Inventor
ZHU WENYU
US44 patents
⚠️ This page may combine multiple inventors who share the name “ZHU WENYU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
36 patentsUS9181271B2Nov 10, 2015
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP105 citations99
US8993605B2Mar 31, 2015
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP34 citations98
US9334274B2May 10, 2016
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
INCYTE CORP57 citations97
US8822511B2Sep 2, 2014
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP24 citations96
US10806785B2Oct 20, 2020
Immunomodulator compounds and methods of use
INCYTE CORP32 citations94
US10092570B2Oct 9, 2018
Heterocyclylamines as PI3K inhibitors
INCYTE CORP17 citations94
US9730939B2Aug 15, 2017
Heterocyclylamines as PI3K inhibitors
INCYTE CORP23 citations94
US9193733B2Nov 24, 2015
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
INCYTE CORP33 citations94
US10034864B2Jul 31, 2018
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP8 citations93
US9789094B2Oct 17, 2017
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP11 citations93
US9540347B2Jan 10, 2017
Pyridineamine compounds useful as Pim kinase inhibitors
INCYTE CORP19 citations93
US9320732B2Apr 26, 2016
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP14 citations93
US9556197B2Jan 31, 2017
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
INCYTE CORP19 citations92
US8951536B2Feb 10, 2015
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
INCYTE CORP25 citations92
US7141596B2Nov 28, 2006
Inhibitors of proteins that bind phosphorylated molecules
INCYTE CORP24 citations89
US11161850B2Nov 2, 2021
Fused pyrazine derivatives as A2A / A2B inhibitors
INCYTE CORP5 citations84
US10653677B2May 19, 2020
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP4 citations84
US10450296B2Oct 22, 2019
Heterocyclic compounds useful as Pim kinase inhibitors
INCYTE CORP6 citations84
US10370387B2Aug 6, 2019
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP6 citations84
US10369137B2Aug 6, 2019
1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP5 citations84
US10000507B2Jun 19, 2018
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
INCYTE CORP12 citations84
US9920032B2Mar 20, 2018
Heterocyclic compounds useful as pim kinase inhibitors
INCYTE CORP12 citations84
US9908895B2Mar 6, 2018
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP8 citations84
US9777017B2Oct 3, 2017
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP9 citations84
US11851442B2Dec 26, 2023
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP1 citations73
US11207302B2Dec 28, 2021
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP1 citations73
US11161855B2Nov 2, 2021
Tricyclic fused thiophene derivatives as JAK inhibitors
INCYTE CORP3 citations73
US11530218B2Dec 20, 2022
Spiro compounds as inhibitors of KRAS
INCYTE CORP3 citations71
US12030884B2Jul 9, 2024
Pyrazoloquinoline KRAS inhibitors
INCYTE CORP0 citations63
US11053215B2Jul 6, 2021
Heterocyclic compounds useful as Pim kinase inhibitors
INCYTE CORP1 citations63
US11939328B2Mar 26, 2024
Quinoline compounds as inhibitors of KRAS
INCYTE CORP0 citations61
US11999740B2Jun 4, 2024
Fused pyrazine derivatives as A2A / A2B inhibitors
INCYTE CORP0 citations59
US12378243B2Aug 5, 2025
Quinoline compounds as inhibitors of KRAS
INCYTE CORP0 citations56
US12466822B2Nov 11, 2025
Heterocyclic compounds as immunomodulators
INCYTE CORP0 citations51
US12060433B2Aug 13, 2024
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy
INCYTE CORP0 citations49
US12030883B2Jul 9, 2024
Hetero-tricyclic compounds as inhibitors of KRAS
INCYTE CORP0 citations49
COMBS ANDREW P
3 patentsUS8088803B2Jan 3, 2012
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
COMBS ANDREW P64 citations99
US8796319B2Aug 5, 2014
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
COMBS ANDREW P21 citations92
US8450351B2May 28, 2013
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
COMBS ANDREW P18 citations91
RODGERS JAMES D
3 patentsUS9034884B2May 19, 2015
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
RODGERS JAMES D91 citations98
US8933085B2Jan 13, 2015
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
RODGERS JAMES D96 citations98
US8716303B2May 6, 2014
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
RODGERS JAMES D109 citations97